The latest quarterly R&D expense is $35.16 Million with a QoQ Growth of +5.19%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Reported quarterly R&D expense; no daily interpolation. Q2 FY2027 (2026-07-31): $35.16M.
$35.16M
$35.16 Million
+5.19%
vs. $33.42M prior quarter
22
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2027Period end 2026-07-31 | $35.16M | +5.19% | +45.54% |
| Q1 FY2027Period end 2026-04-30 | $33.42M | +3.81% | +44.84% |
| Q4 FY2026Period end 2026-01-31 | $32.19M | +17.81% | +40.27% |
| Q3 FY2026Period end 2025-10-31 | $27.33M | +13.13% | +8.37% |
| Q2 FY2026Period end 2025-07-31 | $24.16M | +4.68% | -11.36% |
| Q1 FY2026Period end 2025-04-30 | $23.07M | +0.54% | -9.83% |
| Q4 FY2025Period end 2025-01-31 | $22.95M | -8.98% | -19.22% |
| Q3 FY2025Period end 2024-10-31 | $25.22M | -7.46% | -23.59% |
| Q2 FY2025Period end 2024-07-31 | $27.25M | +6.49% | +1.90% |
| Q1 FY2025Period end 2024-04-30 | $25.59M | -9.93% | -9.21% |
| Q4 FY2024Period end 2024-01-31 | $28.41M | -13.91% | -10.75% |
| Q3 FY2024Period end 2023-10-31 | $33.00M | +23.41% | +19.58% |
| Q2 FY2024Period end 2023-07-31 | $26.74M | -5.13% | +0.01% |
| Q1 FY2024Period end 2023-04-30 | $28.19M | -11.45% | +13.88% |
| Q4 FY2023Period end 2023-01-31 | $31.83M | +15.34% | +17.19% |
| Q3 FY2023Period end 2022-10-31 | $27.60M | +3.22% | N/A |
| Q2 FY2023Period end 2022-07-31 | $26.74M | +8.03% | N/A |
| Q1 FY2023Period end 2022-04-30 | $24.75M | -8.88% | N/A |
| Q4 FY2022Period end 2022-01-31 | $27.16M | N/A | N/A |
| Q3 FY2022Period end 2021-09-30 | $14.96M | +20.33% | N/A |
| Q2 FY2022Period end 2021-06-30 | $12.43M | +2.49% | N/A |
| Q1 FY2022Period end 2021-03-31 | $12.13M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
